ProMIS Neurosciences to Present at Extraordinary Futures Investment Conference
TORONTO and CAMBRIDGE, MA, Sept. 17, 2018 /PRNewswire/ - ProMis Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced that it will be featured as a presenting company at the Extraordinary Futures Investment Conference, sponsored by Cambridge House. The conference is being held on September 19-20, 2018 at the Vancouver Convention Centre East in Vancouver, British Columbia.
Elliot Goldstein, President & CEO of ProMIS Neurosciences will provide a corporate overview in the Workshop 1 room on Thursday, September 20, 2018, at 12:50 p.m. PT, and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. ProMIS will also be hosting a booth at the conference.
If you are an investor and would like to attend the Company's presentation please visit https://cambridgehouse.com/register/74 to register for the conference.
About ProMIS Neurosciences
For more information please visit us at: www.promisneurosciences.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/promis-neurosciences-to-present-at-extraordinary-futures-investment-conference-300713251.html
SOURCE ProMIS Neurosciences Inc.
Company Codes: OTC-QB:ARFXF, Toronto:PMN